WestRock Reports Second Quarter Fiscal 2024 Results BusinessWire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on WRK
    Kuehn Law Encourages LABP, WRK, KAMN and TGAN Investors to Contact Law Firm
    11:08a ET March 27 '24 GlobeNewswire
    Kuehn Law Encourages LABP, WRK, KAMN and TGAN Investors to Contact Law FirmGlobeNewswireMarch 27, 2024

    NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.

    Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:

    Landos Biopharma, Inc. (NASDAQ: LABP)click to participate

    AbbVie Inc. will acquire Landos for $20.42 per share in cash, and each share will come with a non-tradable contingent value right per share up to $11.14 in value, contingent upon reaching a clinical development milestone.

    WestRock Company (NYSE: WRK)click to participate

    WestRock Company has agreed to be acquired by Smurfit Kappa Group for one new Smurfit WestRock share and $5.00 in cash for each share of WestRock common stock. Under the agreement, WestRock stockholders will receive approximately 49.6% of the combined entity.

    Kaman Corp. (NYSE: KAMN)click to participate

    Kaman Corp. is being acquired by Arcline Investment Management, L.P. The agreement stipulates that shareholders of Kaman will receive $46.00 per share in cash upon the completion of the merger.

    Transphorm, Inc. (Nasdaq: TGAN)click to participate

    Transphorm has agreed to be acquired by Renesas Electronics. In accordance with the terms of the merger agreement, shareholders of Transphorm will receive $5.10 in cash for each share of Transphorm common stock they own.

    Why Your Participation Matters:

    As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.(TM)

    How to Get Involved:

    Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.

    Attorney advertising. Prior results do not guarantee similar outcomes.

    Contacts:Kuehn Law, PLLCJustin Kuehn, Esq.53 Hill Street, Suite 605 Southampton, NY 11968justin@kuehn.law(833) 672-0814

    COMTEX_449918517/2010/2024-03-27T11:08:24

    NEW YORK, March 27, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.

    Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:

    Landos Biopharma, Inc. (NASDAQ: LABP)click to participate

    AbbVie Inc. will acquire Landos for $20.42 per share in cash, and each share will come with a non-tradable contingent value right per share up to $11.14 in value, contingent upon reaching a clinical development milestone.

    WestRock Company (NYSE: WRK)click to participate

    WestRock Company has agreed to be acquired by Smurfit Kappa Group for one new Smurfit WestRock share and $5.00 in cash for each share of WestRock common stock. Under the agreement, WestRock stockholders will receive approximately 49.6% of the combined entity.

    Kaman Corp. (NYSE: KAMN)click to participate

    Kaman Corp. is being acquired by Arcline Investment Management, L.P. The agreement stipulates that shareholders of Kaman will receive $46.00 per share in cash upon the completion of the merger.

    Transphorm, Inc. (Nasdaq: TGAN)click to participate

    Transphorm has agreed to be acquired by Renesas Electronics. In accordance with the terms of the merger agreement, shareholders of Transphorm will receive $5.10 in cash for each share of Transphorm common stock they own.

    Why Your Participation Matters:

    As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.(TM)

    How to Get Involved:

    Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.

    Attorney advertising. Prior results do not guarantee similar outcomes.

    Contacts:Kuehn Law, PLLCJustin Kuehn, Esq.53 Hill Street, Suite 605 Southampton, NY 11968justin@kuehn.law(833) 672-0814

    COMTEX_449918517/2010/2024-03-27T11:08:24

    WestRock Announces Quarterly Dividend of $0.3025 Per Share
    10:47a ET April 26 '24 BusinessWire
    WestRock to Release Fiscal Second Quarter 2024 Results on May 2, 2024
    7:00a ET April 19 '24 BusinessWire
    SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates WRK, TGAN, ANSS, IN...
    12:46p ET March 28 '24 PR Newswire
    SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates LABP, WRK, TGAN, KA...
    11:47a ET March 27 '24 ACCESSWIRE
    Kuehn Law Encourages LABP, WRK, KAMN and TGAN Investors to Contact La...
    11:08a ET March 27 '24 GlobeNewswire

    Market data provided by News provided by